Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

  • This share is currently suspended. It was suspended at a price of 81.80
  • There is currently no data for RNO

Director/PDMR Shareholding

2 Mar 2020 14:21

RNS Number : 7263E
Renold PLC
02 March 2020
 

Renold plc

("Renold" or the "Group")

 

Director/PDMR Shareholdings

 

2 March 2020

 

Renold plc ("Renold" or "the Group"), a leading international supplier of industrial chains and related power transmission products, announces that it has been notified of the following transactions in ordinary shares of 5 pence each in the Company ("Ordinary Shares").

 

Mark Harper, Non-Executive-Chairman, purchased 350,000 Ordinary Shares in the Company, at an average price of 11.24 pence per share.

 

Ian Scapens, Group Finance Director, purchased 42,372 Ordinary Shares in the Company, at an average price of 11.80 pence per share.

 

Following these transactions, Mr Harper and Mr Scapens respective beneficial interest in Ordinary Shares, including the beneficial holdings of persons closely associated with them, are as follows:

 

No. of Ordinary Shares

Percentage of issued Ordinary Share capital

Mark Harper

1,056,449

0.47%

Ian Scapens

231,952

0.10%

 

 

ENQUIRIES:

 

Renold plc

0161 498 4500

Robert Purcell, Chief Executive

Ian Scapens, Group Finance Director

Peel Hunt LLP

020 7418 8900

Mike Bell

Ed Allsopp

Instinctif Partners

020 7457 2020

Mark Garraway

Rosie Driscoll

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well-deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

 

 

The information below (set out in accordance with the requirements of EU Market Abuse Regulation) provides further detail:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Harper

2

Reason for the notification

a)

Position/status

Non-Executive Chairman-PDMR

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Renold plc

 

b)

LEI

213800LNDGJY65SP6P54

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5 pence each

Identification code

ISIN: GB0007325078

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

11.69p

50,000

11.46p

50,000

11.41p

100,000

10.93p

50,000

10.88p

100,000

d)

 

Aggregated information

- Aggregated volume

350,000

- Price

11.24p (average)

e)

 

Date of the transaction

 

28 February 2020

f)

 

Place of the transaction

 

London Stock Exchange

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ian Scapens

2

Reason for the notification

a)

Position/status

Group Finance Director-PDMR

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Renold plc

 

b)

LEI

213800LNDGJY65SP6P54

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5 pence each

Identification code

ISIN: GB0007325078

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

11.80p

42,372

d)

 

Aggregated information

- Aggregated volume

42,372

- Price

11.80p (average)

e)

 

Date of the transaction

 

2 March 2020

f)

 

Place of the transaction

 

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBSGDXGDGDGGD
Date   Source Headline
25th Aug 20217:00 amRNSHolding(s) in Company
23rd Aug 202112:11 pmRNSResult of AGM
23rd Aug 20217:00 amRNSAGM Trading Update
12th Aug 20214:40 pmRNSSecond Price Monitoring Extn
12th Aug 20214:35 pmRNSPrice Monitoring Extension
29th Jul 20214:41 pmRNSSecond Price Monitoring Extn
29th Jul 20214:36 pmRNSPrice Monitoring Extension
28th Jul 20217:00 amRNSPosting of Annual Report and Notice of AGM
27th Jul 202112:50 pmRNSDirector/PDMR Shareholding
26th Jul 20218:55 amRNSGrant of Options
19th Jul 202111:23 amRNSDirector/PDMR Shareholding
16th Jul 20217:00 amRNSFinal Results
13th Jul 20217:00 amRNSFlexible Coupling Contract Award
8th Jul 20219:47 amRNSNotice of results for the year ended 31 March 2021
23rd Jun 20213:30 pmRNSHolding(s) in Company
18th Jun 20217:00 amRNSBlock listing Six Monthly Return
16th Jun 20217:00 amRNSNotice of results for the year ended 31 March 2021
15th Jun 20214:40 pmRNSSecond Price Monitoring Extn
15th Jun 20214:35 pmRNSPrice Monitoring Extension
11th Jun 20217:00 amRNSInvestor Presentation – 17 June 2021
28th May 202112:35 pmRNSNotice of Results
27th May 20214:02 pmRNSCapital Reduction
26th May 20218:30 amRNSPreference Stock Dividend
4th May 202110:38 amRNSHolding(s) in Company
15th Apr 20215:27 pmRNSResults of General Meeting
14th Apr 20217:00 amRNSTrading Update for the year ended 31 March 2021
29th Mar 20218:40 amRNSNotice of General Meeting
24th Feb 20215:17 pmRNSHolding(s) in Company
9th Feb 20214:37 pmRNSHolding(s) in Company
5th Feb 202112:26 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSHolding(s) in Company
13th Jan 20217:00 amRNSTrading Update
17th Dec 20207:00 amRNSBlock listing Interim Review
26th Nov 20207:00 amRNSPreference Stock Dividend
23rd Nov 20204:15 pmRNSHolding(s) in Company
20th Nov 20207:00 amRNSAppointment of Non-Executive Director
18th Nov 20204:15 pmRNSHolding(s) in Company
16th Nov 20207:00 amRNSGrant of Awards – Performance Share Plan
11th Nov 20207:00 amRNSHalf-year Report
16th Oct 20207:00 amRNSTrading Update
1st Oct 20208:41 amRNSGrant of Awards - Performance Share Plan
24th Sep 20207:00 amRNSRe: Directorate Change
22nd Sep 20203:20 pmRNSDirector/PDMR Shareholding
18th Sep 20203:50 pmRNSDirector/PDMR Shareholding
11th Aug 20207:00 amRNSPDMR/Directorate Change
24th Jul 20201:23 pmRNSResult of AGM
24th Jul 20207:00 amRNSAGM Statement
26th Jun 20202:57 pmRNSAnnual Report and Accounts
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:37 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.